Molecular Analysis of the Ras-Raf-MAPK Pathway in Langerhans Cell Histiocytosis

被引:0
|
作者
Solomon, David [1 ]
Joseph, Nancy [1 ]
Grenert, James [1 ]
Horvai, Andrew [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
95
引用
收藏
页码:27A / 27A
页数:1
相关论文
共 50 条
  • [1] Molecular Analysis of the Ras-Raf-MAPK Pathway in Langerhans Cell Histiocytosis
    Solomon, David
    Joseph, Nancy
    Grenert, James
    Horvai, Andrew
    MODERN PATHOLOGY, 2015, 28 : 27A - 27A
  • [2] Prohibitin is required for Ras-Raf-MAPK signaling and epithelial cell migration
    Rajalingam, K
    Wunder, C
    Brinkmann, V
    Churin, Y
    Oswald, M
    Rapp, UF
    Rudel, T
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2005, 84 : 35 - 35
  • [3] Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas
    Bläker, H
    Helmchen, B
    Bönisch, A
    Aulmann, S
    Penzel, R
    Otto, HF
    Rieker, RJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (08) : 748 - 753
  • [4] The MAPK Pathway in Pulmonary Langerhans Cell Histiocytosis
    Jouenne, Fanelie
    Tazi, Abdellatif
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (06): : 347 - 349
  • [5] The Ras/Raf/MAPK pathway
    Molina, Julian R.
    Adjei, Alex A.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (01) : 7 - 9
  • [6] microRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma
    Strong, Ashley M. Poenitzsch
    Setaluri, Vijayasaradhi
    Spiegelman, Vladimir S.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 563 : 118 - 124
  • [7] Associations of gene-gene interaction in the Ras-Raf-MAPK signal pathway with antidepressant drug response
    Zhang, Z. J.
    Wang, C. J.
    Pu, M. J.
    Xu, Z.
    Wang, C. Y.
    Liu, Z. N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S388 - S389
  • [8] Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade
    Collisson, EA
    De, A
    Suzuki, H
    Gambhir, SS
    Kolodney, MS
    CANCER RESEARCH, 2003, 63 (18) : 5669 - 5673
  • [9] Clinical Outcomes and Molecular Responses in Children with Langerhans Cell Histiocytosis Treated with MAPK Pathway Inhibitors
    Eckstein, Olive S.
    Zinn, Daniel
    Levy, Carolyn Fein
    Henry, Michael M.
    Campbell, Patrick
    Jordan, Michael B.
    Kumar, Ashish R.
    Rodriguez-Galindo, Carlos
    Hijiya, Nobuko
    Abla, Oussama
    McClain, Kenneth L.
    Allen, Carl E.
    BLOOD, 2018, 132
  • [10] Recurrent activating MAPK pathway gene mutations in Langerhans cell histiocytosis
    Chakraborty, R.
    Hampton, O. A.
    Shen, Xiaoyun
    Simko, S. J.
    Shih, A.
    Abhyankar, H.
    Lim, K. P. H.
    Covington, K. R.
    Trevino, L.
    Dewal, N.
    Muzny, D. M.
    Doddapaneni, H.
    Hu, J.
    Wang, L.
    Lupo, P. J.
    Hicks, M. J.
    Bonilla, D. L.
    Dwyer, K. C.
    Berres, M. L.
    Poulikakos, P. I.
    Merad, M.
    McClain, K. L.
    Wheeler, D. A.
    Parsons, D. W.
    Allen, C. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 18 - 18